Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy
The Journal of Clinical Psychiatry · 21.02.2018 · 79 (1) · 18f12136
DOI: 10.4088/jcp.18f12136 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, erschienen am 21.02.2018. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com.
Zitieren
APA
Andrade, C. (2018). Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy. The Journal of Clinical Psychiatry, 79(1), 18f12136. https://doi.org/10.4088/jcp.18f12136
Vancouver
Andrade C. Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy. The Journal of Clinical Psychiatry. 2018;79(1):18f12136. doi:10.4088/jcp.18f12136
BibTeX
@article{Andrade2018,
author = {Andrade, Chittaranjan},
title = {Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy},
journal = {The Journal of Clinical Psychiatry},
year = {2018},
volume = {79},
number = {1},
pages = {18f12136},
doi = {10.4088/jcp.18f12136}
}
EUVIMED